Published by Medical Xpress
On April 24, 2019
The more cannabidiol (CBD) in a strain of cannabis, the lower the impairment to brain function, finds a new UCL-led brain imaging study.
The research, published in the Journal of Psychopharmacology, is the first study using fMRI (functional magnetic resonance imaging) to gauge how different strains of cannabis impact brain function.
“Over the last two decades, rates of addiction and psychosis linked to cannabis have been on the rise, while at the same time stronger strains of cannabis with more THC and less CBD have become increasingly common,” said the study’s lead author, Dr. Matt Wall (UCL Clinical Psychopharmacology Unit and Invicro).
The NY Hemp Nexus is the place to find breaking news, make connections, and be a part of the New York State Hemp Community.
The Greater Rochester Chamber of Commerce has partnered with HempLab NY to present CannaBusiness: Digging Deeper; a community conversation on the regulation of the rising hemp and cannabis industries in New York state. The state’s efforts on hemp regulation and the...read more
Seven Sages Hemp Co. is in the process of building their hemp brand throughout New York state. Their flagship store is located in the South Wedge neighborhood of Rochester, NY. Their company is based on their interpretation of the seven sages of the cannabis order:...read more
Published on August, 8, 2019 Contributors: Alyssa Piersimoni and Matt Hull With the democratic primaries underway, many people are tuning in on what potential democratic nominees will do for the United States if elected President. The recent CNN Democratic...read more